Amarin Corp Plc (AMRN)

[oneragman]

gg, logic dictates that something is brewing between AMRN and PFE. Let's assume for a second that AMRN really does want to gia. What is the best way to get the maximum value of this approach?
It would be exactly what HLS did in Canada. A partnership in the US would be much better than the current strategy. The prove of that is HLS/PFE deal. AMRN could ditch all their sales reps and pay a percentage of sales to PFE. You instantly more than triple your sales force while becoming significantly profitable much faster. That salesforce also has a lot more influence than AMRN's. The share price would increase dramatically, first just from the PFE association, then from a large increase in sales. Time is of the essence as they can easily outgrow the generics supply. With profitability, they can invest in a pipeline for the future.
As far as the EU, you would still have the option of launching yourself or also turning that over to PFE.
So if AMRN is executing a true gia strategy, what has transpired in the US market doesn't make sense. The fact that there is generic competition is irrelevant due to supply constraints. Lipitor sales in China of over $1B prove that PFE can compete.
The only logical explanation of the action to date is a BO or partnership with PFE. The sooner the better.